Celgene and bluebird bio work together on gene therapy for cancer
Celgene Corp. and bluebird bio LLC (gene therapies for genetic and orphan diseases) have teamed up to discover new cancer treatments that utilize a patient’s own T-cells.
- Gene Therapy, Cell Therapy
- Large Molecule
- Includes Contract
- Includes Royalty or Profit Split Information
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.